| Literature DB >> 28053986 |
Zdeněk Čada1, Zuzana Balatková1, Martin Chovanec2, Ondřej Čakrt3, Silvie Hrubá1, Jaroslav Jeřábek4, Eduard Zvěřina1, Oliver Profant1, Zdeněk Fík1, Martin Komarc5, Jan Betka1, Jan Kluh1, Rudolf Černý4.
Abstract
Surgical removal of vestibular schwannoma causes acute vestibular symptoms, including postoperative vertigo and oscillopsia due to nystagmus. In general, the dominant symptom postoperatively is vertigo. Preoperative chemical vestibular ablation can reduce vestibular symptoms postoperatively. We used 1.0 mL of 40 mg/mL nonbuffered gentamicin in three intratympanic installations over 2 days, 2 months preoperatively in 10 patients. Reduction of vestibular function was measured by the head impulse test and the caloric test. Reduction of vestibular function was found in all gentamicin patient groups. After gentamicin vestibular ablation, patients underwent home vestibular exercising for two months. The control group consisted of 10 patients who underwent only home vestibular training two months preoperatively. Postoperative rates of recovery and vertigo in both groups were evaluated with the Glasgow Benefit Inventory (GBI), the Glasgow Health Status Inventory (GHSI), and the Dizziness Handicap Inventory questionnaires, as well as survey of visual symptoms by specific questionnaire developed by us. There were no statistically significant differences between both groups with regard to the results of questionnaires. Patients who received preoperative gentamicin were more resilient to optokinetic and optic flow stimulation (p < 0.05). This trial is registered with clinical study registration number NCT02963896.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28053986 PMCID: PMC5178333 DOI: 10.1155/2016/6767216
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
| Patients | Age (years) | Side (L: left, R: right) | Size of tumor | Canal paresis (%) | Length of surgery (hours) | |
|---|---|---|---|---|---|---|
| ITG group | 1 | 33 | L | 1 | 40 | 7 |
| 2 | 47 | L | 4 | 41 | 6 | |
| 3 | 65 | R | 3 | 15 | 7 | |
| 4 | 59 | R | 2 | 30 | 7 | |
| 5 | 42 | R | 3 | 40 | 6 | |
| 6 | 40 | L | 4 | 28 | 8 | |
| 7 | 51 | R | 2 | 27 | 8 | |
| 8 | 56 | L | 3 | 34 | 6 | |
| 9 | 59 | L | 4 | 18 | 7 | |
| 10 | 52 | L | 2 | 20 | 8 | |
|
| ||||||
| Control group | 1 | 43 | L | 3 | 9 | 7 |
| 2 | 47 | L | 4 | 7 | 6 | |
| 3 | 60 | R | 4 | 15 | 9 | |
| 4 | 60 | L | 4 | 54 | 11 | |
| 5 | 54 | L | 3 | 40 | 6 | |
| 6 | 56 | R | 3 | 24 | 6 | |
| 7 | 44 | L | 2 | 23 | 8 | |
| 8 | 42 | R | 4 | 18 | 8 | |
| 9 | 52 | L | 4 | 40 | 9 | |
| 10 | 45 | L | 2 | 35 | 5 | |
ITG: intratympanic gentamicin.
Results.
| ITG group | Control group | |||||
|---|---|---|---|---|---|---|
| Mean (SD) |
| Mean (SD) |
|
| ||
| Age | — | 50.40 (9.94) | — | 50.30 (6.98) | — | 0.980 |
|
| ||||||
| GHSI total | Time 1 | 59.81 (14.66) |
| 61.70 (11.56) |
| 0.753 |
| Time 2 | 54.67 (14.74) |
| 51.06 (12.44) |
| 0.574 | |
| Time 3 | 55.28 (11.05) |
| 49.54 (10.84) |
| 0.257 | |
|
| ||||||
| GHSI general | Time 1 | 62.88 (18.75) |
| 65.21 (12.62) |
| 0.748 |
| Time 2 | 54.08 (18.85) |
| 49.69 (14.69) |
| 0.582 | |
| Time 3 | 55.04 (11.91) |
| 47.68 (14.51) |
| 0.231 | |
|
| ||||||
| GHSI social support | Time 1 | 60.00 (8.61) |
| 61.67 (7.03) |
| 0.641 |
| Time 2 | 61.67 (8.96) |
| 65.74 (8.78) |
| 0.332 | |
| Time 3 | 59.17 (9.17) |
| 59.17 (7.30) |
| 1.000 | |
|
| ||||||
| GHSI physical | Time 1 | 48.33 (24.78) |
| 48.33 (21.44) |
| 1.000 |
| Time 2 | 50.83 (22.38) |
| 41.67 (20.83) |
| 0.370 | |
| Time 3 | 52.50 (21.89) |
| 46.67 (16.29) |
| 0.508 | |
|
| ||||||
| DHI | Time 1 | 16.60 (20.13) |
| 21.40 (28.54) |
| 0.669 |
| Time 2 | 32.40 (21.52) |
| 20.00 (18.50) |
| 0.184 | |
| Time 3 | 31.40 (19.46) |
| 43.00 (28.76) |
| 0.305 | |
|
| ||||||
| GBI total | Time 2 | −0.31 (5.28) |
| — | — | — |
| Time 3 | −0.97 (12.76) | — | −8.78 (18.79) | — | 0.291 | |
|
| ||||||
| GBI general | Time 2 | −2.78 (7.51) |
| — | — | — |
| Time 3 | −3.17 (18.49) | — | −20.83 (26.28) | — | 0.099 | |
|
| ||||||
| GBI social support | Time 2 | 14.81 (21.15) |
| — | — | — |
| Time 3 | 15.00 (19.95) | — | 36.67 (15.32) | — |
| |
|
| ||||||
| GBI physical | Time 2 | −5.56 (14.43) |
| — | — | — |
| Time 3 | −8.33 (18.00) | — | −0.83 (33.90) | — | 0.544 | |
Note. SD: standard deviation; p valuew: within-group differences tested by LSD post hoc tests after repeated measures ANOVA; p 1,2: p value of the difference between time 1 and time 2; p 2,3: p value of the difference between time 2 and time 3; p 3,1: p value of the difference between time 1 and time 3; p valueb: between-group differences tested by independent-group t-test; ITG: intratympanic gentamicin.
Figure 1Means and SEM for DHI questionnaire. Time 1: 3 months before surgery, time 2: 2 months before surgery, after pretreatment in the ITG group, and time 3: 3 months after surgery. ANOVA 2-way (time × group) interaction effect p value < 0.05.
Figure 2Means and SEM for question F: Do you have instability with, or does shopping in a supermarket bother you (rapid changes in products on the shelves)? Question_F_1: 3 months before surgery, Question_F_2: 3 weeks after surgery, Question_F_3: 3 months after surgery, and Question_F_4: 1 year after surgery. ANOVA 2-way (time × group) interaction effect p value < 0.05.
Figure 3Means and SEM for question G: Do you have instability with, or does a greater amount of auditory and visual sensations bother you (e.g., shopping centers)? ANOVA 2-way (time × group) interaction effect p value < 0.05. Question_G_1: 3 months before surgery, Question_G_2: 3 weeks after surgery, Question_G_3: 3 months after surgery, and Question_G_4: 1 year after surgery. ANOVA 2-way (time × group) interaction effect p value < 0.05.